Dr. Kolassa is CEO and Partner at Medical Marketing Economics (MME), a consulting firm he founded in 2002. With over 25 years of experience in pricing, Kolassa is also a veteran blues artist! Check out his latest album, Michissippi Mick here. (Source: Dan Harr, Music News nashville, 11/4/14). […]
A Glance At What’s To Come At The ISPOR Annual European Congress
The Institute for Medical Technology Assessment will be well represented at the Annual European International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Congress, which will be held from November 8-12 in Amsterdam. Take a look at these Pre-ISPOR interviews here. (Source: iMTA […]
Healthcare Prices – What Goes Up, Must Come Down!
Healthcare costs have been growing year after year, but recent analyses of 2013 shows patients aren't buying as much. See more from this Health Care Cost Institute report here. (Source: Melanie Evans, Modern Healthcare, 10/28/14). […]
How Do You Decide The Relevance And Credibility Of Observational Studies?
Four Good Practices task forces developed consensus-based questionnaires to help decision makers evaluate: 1) prospective and 2) retrospective observational studies, 3) network meta-analysis, and 4) decision analytic modeling studies with greater uniformity and transparency. Based on feedback from […]
Assess Health Care Research Studies With This Interactive Questionnaire
The 'Assessing the Evidence for Health Care Decision Makers' is an interactive questionnaire for users of evidence to assess health care research studies used in health technology assessments and/or drug formulary decisions. More information available here. (Source: Assessing the Evidence). […]
How Much Higher Are Medical Costs With Hospital-Owned Physician Groups?
Recently released research from the UC Berkeley, looks at hospital ownership of physician groups in California, and the overall impact on healthcare costs. How much did the costs increase? Read more here. (Source: Chad Terhune, Los Angeles Times, 10/21/14). […]
Survey Results On Data Requirements and Availablility in the EU
This survey was distributed to market access personnel from Pfizer in 10 different countries; Poland, the Czech Republic, Slovakia, Hungary, Romania, United Kingdom, France, Germany, the Netherlands, Sweden - to compare data requirements and their availability for health economic evaluations. Survey […]
The History of Health Economics with Patti Peeples from HealthEconomics.Com
Relentless Health Value talks with Patti Peeples, Founder and CEO of HealthEconomics.Com, on the History of Health Economics. Download this podcast here. […]
Did You Catch This Podcast With Relentless Health And Patti Peeples On The History Of Health Economics?
Listen to Dr Patti Peeples discuss the history of health economics and the ethical dilemmas of pricing pharmaceuticals, in this podcast from Relentless Health Value. Podcast available here. (Source: relentlesshealthvalue, 10/16/14). […]
An Introduction To Health Economics and Outcome Research
This one day workshop aims to provide an introductory guide for the non-specialist to identify relevant PROs and pharmacoeconomic evidence in the development of an evaluation strategy. Course details available here. […]
Regression methods for health economic evaluation
More information here. […]
- Previous Page
- 1
- …
- 7
- 8
- 9
